Thermo Fisher Scientific Inc.
0
0
0%

Financials

Income statement

Fundamentals currency is USD
Fiscal date Sep 2025 Jun 2025 Mar 2025 Dec 2024
Total reported revenue 10.2T 9.9T 9.5T 10.4T
Cost of revenue 6.0T 5.9T 5.6T 6.0T
Gross profit 4.2T 4.0T 3.9T 4.4T
Operating expense
Research & development 316.2B 321.7B 312.5B 341.8B
Selling general and admin 2.0T 2.0T 1.9T 2.0T
Other operating expenses
Operating income 1.9T 1.8T 1.7T 2.1T
Non operating interest income
Income 213.8B 271.4B 185.5B 207.4B
Expense 317.1B 369.2B 276.9B 289.7B
Other income expense -125.2B -92.3B -86.8B -195.6B
Pretax income 1.7T 1.6T 1.5T 1.8T
Tax provision 189.2B 84.1B 86.8B 137.1B
Net income 1.5T 1.5T 1.4T 1.7T
Basic EPS 4.3 4.0 4.8
Diluted EPS 4.3 4.0 4.8
Basic average shares 345.4B 345.4B 349.1B
Diluted average shares 345.4B 346.4B 350.0B
EBITDA 2.7T 2.6T 2.5T 2.9T
Net income from continuing op. 1.5T 1.5T 1.4T 1.7T
Minority interests -4.6B -1.8B -3.7B 5.5B
Preferred stock dividends
Access the full /income_statement historical dataset via the API — starting from the Pro plan.
Market closed

Exchange is currently closed
Main market opens in 11 hours 55 minutes

21:34
00:00
09:30
16:00
23:59

Trading Hours (Monday - Friday):

Main market
09:30 - 16:00
All times are displayed in the America/Santiago timezone (-03, UTC-03:00).